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Introduction The aim of this study was to investigate the usefulness of ethyl glucuronide
(EtG) and ethyl sulfate (EtS) as biomarkers of the hangover state.
Methods Thirty‐sixhealthy social drinkers participated in this study, being of naturalistic
design. Eighteen participants experience regular hangovers (the hangover group), whereas the
other 18 claim to not experience a hangover (the hangover‐immune group). On a control day
(alcohol‐free) day and a post‐alcohol day, urine EtG and EtS concentrations were determined
and hangover severity assessed.
Results Urinary EtG and EtS concentrations were significantly increased on post‐alcohol day
compared to the control day (p = .0001). Both EtG and EtS concentrations did not significantly cor-
relate with the overall hangover score, nor with the estimated peak blood alcohol concentrations
and number of alcoholic drinks. EtG correlated significantly only with the individual hangover
symptom “headache” (p = .033; r = .403). No significant correlations were found with the EtG to
EtS ratio. EtG and EtS concentrations significantly correlated with urine ethanol concentrations.
Conclusions Although urine EtG and EtS concentration did not significantly correlate to
estimated peak blood alcohol concentrations or the number of alcoholic drinks consumed, a
significant correlation was found with urine ethanol concentration. However, urine EtG and EtS
concentrations did not significantly correlate with overall hangover severity.
KEYWORDS
alcohol, biomarker, EtG, ethanol, EtS, hangover1 | INTRODUCTION
Alcohol is the most abused drug worldwide, and hangovers are the
most commonly reported adverse consequence of excessive alcohol
consumption. A hangover refers to the combination of mental and
physical symptoms, experienced the day after a single episode of
heavy drinking when the blood alcohol concentrations approaches
zero (van Schrojenstein, Mackus, van de Loo, & Verster, 2016).- - - - - - - - - - - - - - - - - - - - - - - - - - -
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wHangovers do not only have a negative effect on one's health and
well‐being, but also have socioeconomic consequences, such as
missing appointments and poor performance at work (Verster & Frone
2015). For instance, more than half of Dutch long‐haul truck drivers
report driving during the hangover state while they acknowledge that
their driving is less safe and less responsible compared to nondrinking
days (Verster, van der Maarel, McKinney, Olivier, & de Haan, 2014).
This was confirmed by an experimental study that demonstrated- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
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purposes.
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Bervoets, et al., 2014). Of note, the magnitude of driving impairment
was comparable to that observed after consuming alcohol to reach a
blood alcohol concentrations (BAC) of 0.05%, that is, the legal limit
for driving in many countries (Holloway, 1994). Given the potential
risks of being hungover, it is important to identify suitable biomarkers
for the hangover state. At this moment, aside from self‐report, it is not
possible to easily identify people who are suffering from a hangover.
Breath alcohol test readings are likely to be zero (Stephens, Grange,
Jones, & Owen, 2014). Preferably, such a biomarker should be easy
to measure (i.e., quick, noninvasive assessments), with a direct relation-
ship between its concentration in blood, urine, breath, or saliva and
hangover severity, or the magnitude of performance impairment
observed during hangover.
Previous research suggested a potential role for the minor
nonoxidative metabolites ethyl glucuronide (EtG) and ethyl sulfate
(EtS) as a biomarker of the alcohol hangover state (Hoiseth, Fosen,
Liane, Gostrand, & Morland, 2015; Hoiseth et al., 2008; Smith &
Dischinger, 2010; Stephens et al., 2014). EtG is a nonoxidative minor
metabolite of ethanol, formed by the process of glucuronidation, which
is catalyzed by UDP‐glucuronosyltransferase (Foti & Fisher, 2005). EtS
is another nonoxidative metabolite of ethanol, formed by sulfate con-
jugation through the action of cytosolic sulfotransferase (Helander &
Beck, 2005; Wurst et al., 2006). Both EtG and EtS can be determined
in blood, urine, and saliva.
Although the formation of EtG and EtS only represents 0.1% of
total alcohol metabolism, both metabolites can already be determined
after consumption of relative small amounts of ethanol (Hoiseth et al.,
2008). In urine, EtG and EtS are detectable in urine up to 35 hr after
alcohol consumption, opening a detection window that includes the
occurrence of hangover symptoms (Dahl, Stephanson, Beck, &
Helander, 2002; Schmitt, Aderjan, Keller, & Wu, 1995). Therefore,
even if ethanol is no longer detectable in breath, recent alcohol con-
sumption can still be demonstrated by the presence of EtG and EtS
(Helander & Beck, 2005).
Up to now, research on the possible relationship of EtG and EtS
concentration and hangover severity is limited. Hoiseth et al. (2015)
investigated the prevalence of hungover drivers and corresponding
concentrations of EtG and EtS in blood. Out of 146 cases, 90 of the
drivers were judged to be impaired in their driving. In only 16 of these
90 cases of impaired driving, blood samples were tested positive for
both EtG and EtS. Nevertheless, concentrations of EtG and EtS signif-
icantly correlated to the degree of impairment. Another study investi-
gating injured patients after alcohol consumption revealed that in 17%
of them, EtG and EtS could be detected in their blood, despite their
BAC having returned to zero. However, in this study, no significant
correlation was found between EtG and EtS concentrations, hangover
severity, and the magnitude of driving impairment (Bogstrand, Hoiseth,
Rossow, Normann, & Ekeberg, 2014). Neumann et al. (2008) deter-
mined blood EtG concentration to demonstrate recent alcohol use of
emergency room patients. Blood samples from minimally injured and
clinically nonintoxicated patients were collected. Although 38% of
these patients tested positive for EtG, their blood EtG concentration
did not correlate significantly with their scores on the Alcohol Use
Disorders Identification Test (AUDIT).In summary, inconclusive results have been presented regarding
the association of EtG/EtS concentration and hangover severity,
alcohol consumption outcomes, and performance impairment.
Therefore, the aim of this study was to further examine the relation-
ship between EtG and EtS concentrations and hangover severity.
Whereas previous studies determined EtG and EtS in blood, this study
assessed these metabolites in urine, as this noninvasive method of data
collection is less of a burden to participants.2 | METHODS
Social drinkers (N = 36), 18–30 years old, who reported to consume at
least five alcoholic beverages per occasion, at least three times per
month, were recruited. To be included, subjects had to be healthy vol-
unteers that consume sufficient amounts of alcohol to produce an
alcohol hangover. The latter was defined as having an estimated peak
BAC % (wt/vol) of at least 0.08%, as the majority of drinkers report
having a hangover when exceeding this BAC level (Verster, de Klerk,
Bervoets, & Kruisselbrink, 2013). This was determined by asking sub-
jects how many alcoholic drinks they usually consume within a certain
time frame. In the Netherlands, a standardized alcoholic consumption
contains 10 g of ethanol. Their estimated peak BAC was computed
using Watson, Watson, and Batt (1981) formula, which considers
drinking time and amount of alcohol consumed, and controls for gen-
der and body weight. Recreational drug users and smokers were
excluded from participation in the study. N = 18 subjects who report
having hangovers, and N = 18 subjects who report not to have hang-
overs after heavy alcohol consumption (i.e., having an estimated peak
BAC > 0.08%) participated in the study. The University of Groningen
Psychology Ethics Committee approved the study, and written
informed consent was obtained from all participants.
The study consisted of a post‐alcohol day and an alcohol‐free con-
trol day. In the evening, subjects consumed alcohol in a setting of their
own choice. In this so‐called naturalistic study design, the investigators
are not present during the drinking session and no constraints were
posed on their (drinking) behavior. Participants were however
instructed not to use recreational drugs or smoke cigarettes. They
were asked not to consume any alcoholic nor caffeinated beverages
24 hr prior to the alcohol‐free control day.
On test days, subjects came to the institute in the morning. Urine
samples were collected at 09.30 a.m. In addition, several subjective
assessments were made (for a detailed description, see Hogewoning
et al., 2016). Subjects reported the number and type of alcoholic bev-
erages that were consumed the evening before the test day and the
duration of alcohol consumption. This allowed calculating their esti-
mated peak BAC (Watson et al., 1981). A 1‐item overall hangover
severity score, and the severity score of 23 individual hangover symp-
toms were rated on a 11‐point scale, ranging from 0 (absent) to 10
(extreme; Hogewoning et al., 2016). The 23 individual‐assessed hang-
over symptoms were headache, nausea, concentration problems,
regret, sleepiness, heart beating, vomiting, tiredness, shaking, clumsi-
ness, weakness, dizziness, apathy, sweating, stomach pain, confusion,
light sensitivity, thirst, heart racing, anxiety, depression, reduced appe-
tite, and sleep problems. The AUDIT was completed to identify
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(Saunders, Aasland, Babor, de la Fuente, & Grant, 1993), and the Self
Rating of the Effects (SRE) of alcohol was completed to assess the level
of response to alcohol (Schuckit, Smith, & Tipp, 1997).2.1 | Urine collection, handling, and analysis
Any turbid urine samples were centrifuged at 3,000 rpm for 15 min at
room temperature. The urine was stored in three 4 ml cryovials, at a
temperature of −20 °C. Urine samples from volunteers were analyzed
using solid‐phase extraction and ultrahigh‐performance liquid chroma-
tography (UHPLC) coupled to mass spectrometry (MS). Calibration
standards were prepared by spiking blank urine with known amounts
of EtG and EtS and were further pretreated as unknown samples.
Ethyl‐d5 sulfate and ethyl‐d5 glucuronide (Medichem, Steinenbronn,
BW, Germany) were added as internal standards to a 200‐μl volume
of sample and the solution was diluted with 800 μl acetonitrile (ACN)
containing 0.1% ammonium hydroxide (NH4OH). Oasis MAX solid‐
phase extraction cartridges (Waters, Milford, MA, USA) were condi-
tioned with 1 ml methanol (MeOH) and 1 ml 0.1% NH4OH in ACN:
water 80:20% (vol/vol) before loading 1 ml of diluted sample. The car-
tridges were then washed with 0.5 ml ACN, and the analytes were
eluted with 1 ml 0.01 M hydrochloric acid. Eluates were evaporated
at 40 °C under a stream of nitrogen and reconstituted in 100 μl water.
A 5‐μl volume of pretreated sample was injected on a 1290 Infinity
UHPLC system (Agilent Technologies, Wald‐Bronn, BW, Germany)
containing an Acquity UPLC HSS T3 2 mm× 100 mm column with
1.8 μm sized particles (Waters). Compounds were separated within
3 min using an eluent consisting of MeOH:25 mM formic acid 1:99%
(vol/vol) at a flow rate of 0.3 ml/min and detected with a 1,100 series
ion trap mass spectrometer equipped with an electrospray ionization
interface (Agilent Technologies). EtG, ethyl‐d5 glucuronide, EtS, and
Ethyl‐d5 sulfate were detected as [M‐H]− ions at m/z 221, 226, 125,
and 130, respectively.
The method was validated in urine between 0.1–40 μg/ml for EtS
and 0.1–10 μg/ml for EtG.
Calibration curves were linear within this range, extraction recov-
eries were 86% for EtS and 93% for EtG, inter‐day and intra‐day accu-
racies were 80.7–109.8%, and inter‐day and intra‐day precision
coefficients of variation were 3.0–17.0% (n = 6 on 3 different days,
at concentration levels of 0.1, 0.2, 4.0, and 10.0 μg/ml for EtG and
0.1, 0.2, 4.0, and 40.0 μg/ml for EtS). Samples were stable for at least
12 hr at room temperature allowing overnight UHPLC–MS analysis.
In addition to EtG and EtS, urine ethanol concentrations were
assessed; methodology described elsewhere (Van de Loo et al., 2016).2.2 | Statistical analyses
Statistical analyses were performed with SPSS, version 24. Urine EtG
and EtS concentration of the hangover and control day were compared
using nonparametric Mann–WhitneyU tests. In addition to EtG and EtS
concentration, also their ratio (EtG/EtS) was calculated. Difference
scores (post‐alcohol day—control day)were calculated for each variable.
EtG and EtS concentrations were correlated with overall hangover
severity, and severity scores for the individual hangover symptoms(nonparametric, Spearman's r), AUDIT and SRE scores, number of
drinks consumed, estimated BAC, and urine ethanol concentration.
The analyses were conducted for all participants together (N = 36)
and separate for the hangover group and the hangover‐immune group.3 | RESULTS
Participants were aged 21 (±1.79), of which 61% men and 39%
women. There were no sex differences between the hangover sensi-
tive and resistant group. On average, participants consumed
11.6 ± 6.1 alcoholic drinks. Participants had an average score of
12.81 (±4.48) on the AUDIT and 8.35 (±1.70) on the SRE. No signifi-
cant differences were found between the “hangover” and the “hang-
over‐immune” drinkers regarding the number of alcoholic beverages
consumed (12.5 vs. 10.7 drinks, p = .61), nor did their estimated peak
BAC (0.19% vs. 0.17%, p = .382).
Urinary concentrations of both EtG and EtS were significantly
higher on post‐alcohol day compared with the control day
(p = .0001). On post‐alcohol day, EtG was detected in significantly
higher concentrations than EtS (p = .001) in both groups.
No significant differences in EtG and EtS concentrations were
observed between participants with a hangover and those claiming
to be resistant to hangovers. In the hangover group, the urinary con-
centration of EtG was significantly increased on post‐alcohol day
(p = .004), as well as the urinary EtS concentration (p = .000). In the
hangover‐immune group, concentrations of EtG and EtS were also
found to be significantly increased on post‐alcohol day (p = .010 and
p = .003 respectively). Urinary concentrations of EtG and EtS, and their
ratio, are shown in Table 1.
For all participants (N = 36), the scores of all hangover symptoms
were significantly higher on post‐alcohol day, except for the symptoms
‘anxiety” (p = .213) and “depression” (p = .324; for a detailed discussion,
see Hogewoning et al., 2016). In the hangover group, mean (SD) head-
ache severity on the post‐alcohol day was 5.3 (2.9) compared to 2.0
(0.0) in the hangover‐immune group. The 1‐item overall hangover
severity score did not significantly correlate with urinary concentra-
tions of neither EtG, nor of EtS, nor their ratio. Regarding individual
hangover symptoms, urinary EtG concentration on post‐alcohol day
correlated significantly only with “headache” (p = .033; r = .403). Uri-
nary EtS concentration did not significantly correlate with any of the
individual hangover symptoms. Analyzing the data separately for the
hangover group and the hangover‐immune group revealed that for nei-
ther of the two groups, EtG, EtS, or their ratio correlated significantly
with the 1‐item overall hangover severity score, or any of the individ-
ual hangover symptoms (see Table 2).
For all participants (N = 36), urine concentrations of EtG and EtS
significantly correlated with urine ethanol concentrations on the
post‐alcohol day (p = .003, r = .533; p = .002, r = .545, respectively).
No significant correlations were found with the estimated peak BAC
or the number of alcoholic drinks consumed. The EtG/EtS ratio did
not significantly correlate with urine ethanol concentration, estimated
peak BAC, or the number of alcoholic drinks consumed.
A significant correlation between urine EtG and ethanol concen-
tration was also found in the “hangover‐immune” group, but not for
TABLE 1 Urine EtG and EtS determinations
Subject Control day Post‐alcohol day
EtG EtS Ratio EtG EtS Ratio
Hangover group urinary
EtG and EtS (μg/ml)
S101 0.00 0.00 0.00 269.630 88.220 3.06
S102 0.00 0.00 0.00 10.620 22.860 0.46
S103 0.030 0.245 0.12 202.550 66.550 3.04
S104 0.00 0.262 00.00 632.725 121.500 5.21
S105 0.00 0.083 0.00 191.370 90.000 2.13
S106 0.131 0.00 0.00 63.060 21.750 2.90
S107 0.127 0.063 2.00 78.050 15.720 4.97
S108 0.405 0.758 0.53 303.650 83.225 3.65
S109 0.058 0.059 0.99 68.870 45.280 1.52
S110 0.00 0.00 0.00 — 60.270 —
S111 0.015 0.102 0.15 9.866 4.204 2.35
S112 2.226 0.337 6.60 474.025 84.150 5.63
S113 0.015 0.046 0.33 83.250 21.710 3.83
S114 0.052 0.017 2.98 15.350 4.910 3.13
S115 0.138 0.162 0.85 122.980 23.910 5.14
S116 0.379 0.753 0.50 8.000 3.500 2.29
S117 0.00 0.00 0.00 81.200 33.760 2.41
S118 0.015 0.039 0.39 199.640 93.230 2.14
M 0.257 195.13 1.10 165.579 49.153 2.99
SD 0.58 0.249 1.80 174.166 37.139 1.57
Range 0–2.226 0–0.758 0–6.60 0–632.725 3500.00–121.500 0–5.63
Hangover‐immune group urinary
EtG and EtS (μg/ml)
S201 0.00 0.00 0.00 88.080 51.400 1.71
S202 0.00 0.00 0.00 118.980 37.560 3.17
S203 0.00 0.00 0.00 — — —
S204 0.00 0.00 0.00 — — —
S205 0.00 0.00 0.00 27.110 9.052 2.99
S206 0.025 0.009 2.81 116.110 56.060 2.07
S207 0.099 0.090 1.09 53.280 33.860 1.57
S208 0.317 0.122 2.61 241.390 99.290 2.43
S209 2.703 1.311 2.06 8.907 1.605 5.55
S210 0.00 0.46 0.00 60.510 55.510 1.09
S211 0.00 0.00 0.00 4.827 0.295 16.37
S212 1.540 0.275 5.61 210.010 54.390 3.86
S213 0.015 0.094 0.16 4.922 4.516 1.09
S214 0.118 0.00 0.00 30.300 17.060 1.78
S215 0.015 0.00 0.00 0.832 0.315 2.64
S216 0.095 0.006 14.77 77.200 26.390 2.93
S217 0.015 0.00 0.00 4.608 0.452 10.19
S218 0.153 0.013 11.43 321.120 73.900 4.35
M 0.365 0.140 2.90 85.512 32.603 3.99
SD 0.7834 0.346 4.66 95.969 30.316 3.98
Range 0–2.703 0–1.311 0–14.77 0–321.120 0–99.290 0–16.37
Note. Mean, SD, and range are presented. EtG = ethyl glucuronide; EtS = ethyl sulfate; SD = standard deviation.
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significance (see Table 3).4 | DISCUSSION
Urine EtG and EtS concentrations were significantly increased on post‐
alcohol day compared to the alcohol‐free control days for all partici-
pants as well as in both groups. A significant relationship was found
between their concentration and urine ethanol concentration. These
findings confirm the usefulness of EtG and EtS as biomarkers for
recent alcohol use. However, neither EtG, nor EtS concentrations,
nor their ratio did not significantly correlated with the 1‐item overall
hangover severity score, nor with any of the individual hangover symp-
toms (with the exception of headache). Urine concentrations of EtG
and EtS did not significantly differ between drinkers from the hangover
group and drinkers from the hangover‐immune group.
Our findings are in line with previous studies that also failed to
demonstrate a significant relationship between blood EtG and EtSconcentration and hangover severity (Bogstrand et al., 2014), although
one study (Hoiseth et al., 2015) reported a significant relationship
between EtG and EtS concentration and degree of driving impairment,
(not impaired, mildly impaired, moderately impaired, or considerably
impaired). However, the observed correlations were only modest
(r = .170 and r = .189, respectively). Although we did not find a
significant relationship between the EtG and EtS concentrations and
the presence and severity of the alcohol hangover, it may be
interesting for future research to also look at any relationship with
performance impairment.
The only symptom that significantly correlated with EtG concen-
tration on post‐alcohol day was headache (r = .403). It is unclear why
we observed this significant association with headache and not with
any other hangover symptoms. Headache is commonly experienced,
and was reported both on the control day (10 participants) and on
the post‐alcohol day (21 participants). As expected, all 15 participants
that reported no headache after drinking were in the hangover‐
immune group. A clear distinction between the hangover group and
hangover‐immune group was observed regarding the severity of
TABLE 3 Correlations of urinary EtG and EtS concentrations, and EtG to EtS ratio with urinary ethanol concentrations, estimated BAC, and
number of alcoholic drinks
Overall Hangover group Hangover‐immune group
EtG EtS Ratio EtG EtS Ratio EtG EtS Ratio
Urinary ethanol (mg/ml) 0.533** 0.545** −0.032 0.433 0.400 −0.042 0.660* 0.513 0.304
eBAC 0.219 0.128 0.132 0.007 −0.100 0.103 0.165 0.533 0.108
Number of alcoholic drinks 0.267 0.225 −0.077* 0.133 0.054 0.049 0.523 0.483 0.046
Note. Correlations are shown for the overall population, and for the “hangover” and “hangover‐immune” group separately. BAC = blood alcohol
concentrations; EtG = ethyl glucuronide; EtS = ethyl sulfate.
*p < .05.
**p < .01.
TABLE 2 Correlations of urinary concentrations and ratio of EtG and EtS with hangover severity, hangover symptoms, and urinary ethanol
concentrations
Hangover group Hangover‐immune group
EtG EtS EtG/EtS ratio EtG EtS EtG/EtS ratio
1‐item overall hangover score 0.120 0.194 −0.098 −0.425 −0.314 −0.092
Sleepiness 0.322 0.463 −0.169 −0.284 −0.119 0.137
Sweating −0.176 −0.229 0.064 0.328 0.281 0.328
Concentration problems 0.233 0.458 −0.449 −0.145 −0.116 0.145
Nausea 0.216 0.286 −0.069 0.000 0.152 0.152
Thirst −0.408 −0.174 −0.453 0.125 0.116 0.018
Sleep problems −0.032 −0.040 0.296 −0.378 −0.241 0.310
Heart racing 0.372 0.062 0.554 −0.034 −s0.103 0.310
Dizziness 0.058 0.078 −0.047 0.034 0.103 −0.310
Confusion 0.218 0.098 0.145 0.378 0.447 −0.103
Shaking 0.147 0.152 0.680 0.034 0.103 −0.310
Headache 0.155 0.264 −0.093 0.199 0.126 0.297
Regret 0.177 0.298 −0.170 0.234 0.094 0.469
Weakness −0.257 −0.117 −0.182 −0.090 0.036 0.049
Clumsy 0.069 0.149 −0.141 −0.436 −0.240 −0.157
Stomach paina 0.022 −0.057 0.262 — — —
Heart beatinga 0.307 0.298 0.165 — — —
Anxiety 0.046 −0.220 0.407 −0.034 −0.103 0.310
Depression 0.141 −0.085 0.328 −0.034 −0.103 0.310
Reduced appetite 0.313 0.386 0.005 0.051 0.101 0.405
Light sensitivity −0.118 0.062 −0.234 0.447 0.182 0.241
Vomiting 0.329 0.313 0.095 −0.103 −0.241 0.447
Tired −0.069 0.184 −0.508 −0.216 0.009 −0.171
Apathy 0.154 0.229 −0.013 0.094 0.133 0.400
aDifference scores for heart beating and stomach pain were zero for each individual in the hangover‐immune group.
MACKUS ET AL. 5 of 6headache, finding higher scores on headache in the hangover group
compared to the hangover‐immune group.
As for any study using a naturalistic design, some common limita-
tions also apply for this study. For instance, factors such as alcohol
consumption and participant behavior were not controlled. This means
that activities of participants varied (e.g., dancing or drinking in a pub),
as did the type of alcoholic beverage consumed. Although urine sam-
ples were collected at a fixed time point for every participant, the time
between the last alcoholic consumption and urine collection also var-
ied between participants. Although beverage consumption during thedrinking session was recorded, no information was collected on urine
voiding during drinking or during the night. The possible consumption
of water during the night or earlymorningmay have diluted the concen-
tration of EtG and EtS in the bladder. Voiding during night or in the early
morningmay have led to the excretion of EtG and EtS. There is however
no reason to assume that these behaviors have differed between the
hangover group and hangover‐immune group, as these did not differ
significantly on total alcohol consumed and estimated BAC.
In summary, urinary concentrations of EtG and EtS are unrelated
to the presence and severity of the alcohol hangover. Nevertheless,
6 of 6 MACKUS ET AL.EtG and EtS may be useful markers of recent alcohol consumption, as
both significantly correlate with urinary ethanol concentrations on
post‐alcohol day.
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